Panic Disorder: Dysfunctions in the Brain?s Alert System and Combined Therapeutic Interventions

References

[1] American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC.

[2] Baldwin, D. S., Aitchison, K., Bateson, A., Curran, H. V., Davies, S., Leonard, B., & Wilson, S. (2014). Benzodiazepines: Risks and benefits. A reconsideration. Journal of Psychopharmacology, 28(11), 967–971.

[3] Bandelow, B., Michaelis, S., & Wedekind, D. (2017). Treatment of anxiety disorders. Dialogues in Clinical Neuroscience, 19(2), 93–107.

[4] Ball, T. M., Knapp, M. J., & Timpano, K. R. (2018). Biomarkers in anxiety disorders: A review. Neuroscience and Biobehavioral Reviews, 91, 166–178.

[5] Craske, M. G., Kircanski, K., Zelikowsky, M., Mystkowski, J., Chowdhury, N., & Baker, A. (2010). Optimizing inhibitory learning during exposure therapy. Behaviour Research and Therapy, 58, 10–23.

[6] Craske, M. G., Stein, M. B., Eley, T. C., Milad, M. R., Holmes, A., Rapee, R. M., & Wittchen, H. U. (2017). Anxiety disorders. Nature Reviews Disease Primers, 3(1), 17024.

[7] Etkin, A., & Wager, T. D. (2007). Functional neuroimaging of anxiety: A meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. American Journal of Psychiatry, 164(10), 1476–1488.

[8] Freeman, D., Reeve, S., Robinson, A., Ehlers, A., Clark, D., Spanlang, B., & Slater, M. (2017). Virtual reality in the assessment, understanding, and treatment of mental health disorders. Psychological Medicine, 47(14), 2393–2400.

[9] Gorman, J. M., Kent, J. M., Sullivan, G. M., & Coplan, J. D. (2000). Neuroanatomical hypothesis of panic disorder, revised. American Journal of Psychiatry, 157(4), 493–505.

[10] Hofmann, S. G., Asnaani, A., Vonk, I. J., Sawyer, A. T., & Fang, A. (2012). The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research, 36(5), 427–440.

[11] Kim, M. J., Loucks, R. A., Palmer, A. L., Brown, A. C., Solomon, K. M., Marchante, A. N., & Whalen, P. J. (2011). The structural and functional connectivity of the amygdala: From normal emotion to pathological anxiety. Behavioural Brain Research, 223(2), 403–410.

[12] Kumar, S., Feldman, M., & Hsieh, J. C. (2013). Mindfulness-based cognitive therapy in anxiety disorders: A meta-analysis. Psychiatry Research, 210(3), 1233–1241.

[13] LeDoux, J. E. (2007). The amygdala. Current Biology, 17(20), R868-R874.

[14] Maron, E., & Nutt, D. (2017). Biological mechanisms underlying anxiety disorders: Implications for treatment. Psychiatry and Clinical Neurosciences, 71(6), 421–434.

[15] Mayo-Wilson, E., Dias, S., Mavranezouli, I., Kew, K., Clark, D., Ades, A., & Pilling, S. (2014). Psychological and pharmacological interventions for social anxiety disorder in adults: A systematic review and network meta-analysis. The Lancet Psychiatry, 1(5), 368–376.

[16] Meuret, A. E., Wilhelm, F. H., Ritz, T., & Roth, W. T. (2010). Feedback of end-tidal pCO2 as a therapeutic approach for panic disorder. Journal of Psychiatric Research, 44(10), 616–621.

[17] Millan, M. J., Marin, P., Bockaert, J., & Mannoury la Cour, C. (2019). Signaling pathways underlying anxiety and depression: Molecular targets and therapeutic strategies. Pharmacology & Therapeutics, 204, 107402.

[18] Mitte, K. (2005). Meta-analysis of cognitive-behavioral treatments for generalized anxiety disorder: A comparison with pharmacotherapy. Psychological Bulletin, 131(5), 785–795.

[19] Nakatani, E., Akechi, T., Furukawa, T. A., Ikeda, M., Nakano, T., Watanabe, K., & Okuyama, T. (2003). Neural correlates of the treatment response to cognitive-behavioral therapy in panic disorder. Biological Psychiatry, 54(11), 1196–1201.

[20] Nutt, D. J., & Malizia, A. L. (2001). New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. British Journal of Psychiatry, 179(5), 390–396.

[21] Pannekoek, J. N., Veer, I. M., van Tol, M. J., van der Werff, S. J., Demenescu, L. R., Aleman, A., & Rombouts, S. A. (2013). Aberrant resting-state functional connectivity in limbic and salience networks in treatment-naïve clinically depressed patients. Journal of Affective Disorders, 159, 86–94.

[22] Paulesu, E., Sambugaro, E., Torti, T., Danelli, L., Ferri, F., Scialfa, G., & Galimberti, C. A. (2010). Neural correlates of fear conditioning in panic disorder: A functional MRI study. Psychiatry Research: Neuroimaging, 182(2), 169–175.

[23] Ritz, T., Wilhelm, F. H., & Roth, W. T. (2013). Respiratory psychophysiology of panic attacks and anxiety. Psychological Bulletin, 139(6), 1472–1504.

[24] Roy-Byrne, P. P., Craske, M. G., Stein, M. B., Sullivan, G., Bystritsky, A., Katon, W., & Sherbourne, C. (2006). A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Archives of General Psychiatry, 63(3), 290–298.

[25] Roy-Byrne, P. P., Stang, P., Wittchen, H. U., Ustun, B., Walters, E. E., & Kessler, R. C. (2005). Lifetime panic-depression comorbidity in the National Comorbidity Survey. Archives of General Psychiatry, 53(3), 216–224.

[26] Freitas, G. B., Rabelo, E. M., & Pessoa, E. G. (2023). Projeto modular com reaproveitamento de container maritimo. Brazilian Journal of Development, 9(10), 28303–28339. https://doi.org/10.34117/bjdv9n10-057

[27] Gotardi Pessoa, E. (2025). Analysis of the performance of helical piles under various load and geometry conditions. ITEGAM-JETIA, 11(53), 135-140. https://doi.org/10.5935/jetia.v11i53.1887

[28] Gotardi Pessoa, E. (2025). Sustainable solutions for urban infrastructure: The environmental and economic benefits of using recycled construction and demolition waste in permeable pavements. ITEGAM-JETIA, 11(53), 131-134. https://doi.org/10.5935/jetia.v11i53.1886

@article{1710237,
      author = {William Silva Carvalho},
      title = {Panic Disorder: Dysfunctions in the Brain?s Alert System and Combined Therapeutic Interventions},
      journal = {Iconic Research And Engineering Journals},
      year = {2022},
      volume = {5},
      number = {7},
      pages = {565-569},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1710237.pdf},
      abstract = {Panic disorder is a severe anxiety condition characterized by sudden and recurrent panic attacks, often accompanied by significant physiological and psychological distress. Neurobiological evidence indicates that dysfunctions in the brain?s alert system, particularly within the amygdala and related fear-processing networks, play a central role in the pathogenesis of the disorder. Hyperactivation of the amygdala, reduced inhibitory control from prefrontal cortical regions, and imbalances in neurotransmitter systems such as serotonin, GABA, and norepinephrine contribute to the heightened threat perception and somatic symptoms observed in affected individuals. Current best practices in treatment emphasize a combined therapeutic approach, integrating pharmacological strategies?especially selective serotonin reuptake inhibitors (SSRIs)?with cognitive-behavioral therapy (CBT) interventions. Techniques such as progressive desensitization and breathing retraining have demonstrated efficacy in modulating both cognitive distortions and physiological dysregulation. Emerging modalities, including mindfulness-based interventions and virtual reality exposure therapy, may offer additional benefits. This paper reviews the neurobiological mechanisms underlying panic disorder and critically evaluates the effectiveness of combined treatment strategies, advocating for integrated and personalized care models.},
      keywords = {Panic disorder; Amygdala; Fear circuitry; Cognitive-behavioral therapy; SSRIs; Progressive desensitization; Breathing retraining; Neurobiology; Combined therapy; Anxiety treatment.},
      month = {January},
  }